Bio-Rad Laboratories (BIO) risk factors, FY2024 10-K

Business, Economic, Legal and Industry Risks

1. 01Our international operations expose us to additional costs and legal and regulatory risks, which could have a material adverse effect on our business, results of operations and financial condition
2. 02The industries and market segments in which we operate are highly competitive, and we may not be able to compete effectively
3. 03We may not be able to grow our business because of our failure to develop new or improved products
4. 04Global economic and geopolitical conditions could adversely affect our operations
5. 05Reductions in government funding and the capital spending programs of our customers could have a material adverse effect on our business, results of operations or financial condition
6. 06A reduction or interruption in the supply of components and raw materials has adversely affected and could continue to adversely affect our manufacturing operations and related product sales
7. 07Breaches of our information systems could have a material adverse effect on our business and results of operations
8. 08If our information technology systems are disrupted, or if we fail to successfully implement, manage and integrate our information technology and reporting systems, our business, results of operations and financial condition could be harmed
9. 09We are subject to foreign currency exchange fluctuations, which could have a material adverse effect on our results of operations and financial condition
10. 10Changes in the market value of our position in Sartorius AG materially impact our financial results
11. 11The value of our position in Sartorius AG might cause us to be deemed an investment company under the Investment Company Act of 1940
12. 12We have incurred and may continue to incur losses in future periods due to write-downs in the value of our financial instruments
13. 13Recent and planned changes to our organizational structure could negatively impact our business

Risks relating to intellectual property rights may negatively impact our business

1. 14Changes in the healthcare industry could have an adverse effect on our business, results of operations and financial condition
2. 15We are subject to substantial government regulation, and any changes in regulation or violations of regulations by us could adversely affect our business, prospects, results of operations or financial condition
3. 16The FDA has issued a final rule applicable to certain clinical diagnostic products referred to as laboratory developed tests. This change in the FDA approach could negatively impact our customers who use our Life Science products for laboratory developed tests
4. 17We cannot assure you that we will be able to integrate acquired companies, products or technologies into our company successfully, or that we will be able to realize the anticipated benefits from the acquisitions
5. 18Product quality and liability issues could harm our reputation and negatively impact our business, results of operations and financial condition
6. 19Lack of key personnel could hurt our business
7. 20We may have higher than anticipated tax liabilities
8. 21Changes in tax laws or rates, changes in the interpretation of tax laws or changes in the jurisdictional mix of our earnings could adversely affect our financial position and results of operations
9. 22Environmental, health and safety regulations and enforcement proceedings may negatively impact our business, results of operations and financial condition
10. 23Use of generative AI and other AI technologies presents risks and challenges due to the evolving nature of AI
11. 24Our current and future debt and related covenants may restrict our future operations
12. 25We are subject to healthcare laws and regulations and could face substantial penalties if we are unable to fully comply with such laws

Risks Related to Our Common Stock

1. 26A significant majority of our voting stock is held by the Schwartz family, which could lead to conflicts of interest
2. 27The forum selection provision in our bylaws could increase costs to bring a claim, discourage claims or limit the ability of the Company’s stockholders to bring a claim in a judicial forum viewed by the stockholders as more favorable for disputes with the Company or the Company’s directors, officers or other employees
3. 28of forum provision contained in the Company’s bylaws to be inapplicable or unenforceable in an action, the Company may incur additional costs associated with resolving such action in other jurisdictions